Quadruplet Versus Triplet Regimens in Multiple Myeloma

Sarah Holstein, MD, PhD, explains her rationale for choosing a triplet regimen over a quadruplet in patients with multiple myeloma. 

Sarah Holstein, MD, PhD, associate professor at the University of Nebraska Medical Center, explains her rationale for choosing a triplet regimen over a quadruplet in patients with multiple myeloma.

Holstein does not use quadruplet regimens outside of clinical trials because the treatment paradigm is not quite there, she says. However, she tries to use triplet combinations in the majority of her patients.